---
title: MyBiotech GmbH vs Sophia CDMO
slug_a: mybiotech
slug_b: sophiacdmo
site: cdmo
review_signal_gate: closed
canonical_path: /compare/mybiotech/sophiacdmo
---

# MyBiotech GmbH vs Sophia CDMO

Side-by-side profile data from each company listing on this directory.

## MyBiotech GmbH

- Profile: [/companies/mybiotech](/companies/mybiotech)

MyBiotech GmbH — Germany-based CDMO specializing in nanoparticle formulation, process development, GMP manufacturing, and aseptic fill-finish for nanomedicines and advanced drug delivery products.

Services: 9. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Data not yet provided.

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials

## Sophia CDMO

- Profile: [/companies/sophiacdmo](/companies/sophiacdmo)

Sophia CDMO — European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.

Services: 18. Modalities: 5. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (18).

### Services

- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Oligonucleotide Manufacturing
- Peptide Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Lyophilization (Freeze Drying)
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- Extractables & Leachables Studies
- CMC Regulatory Submission Support

### Modalities

- Biologics (Other)
- Oligonucleotide
- mRNA
- Peptide
- Microbiome Therapeutic

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Lyophilized Vials
- Prefilled Syringes (PFS)
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Microbial
- Stainless Steel